Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enfusion Inc Cl A (NY: ENFN )

9.390 +0.080 (+0.86%)
Streaming Delayed Price Updated: 9:34 AM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enfusion Inc Cl A

< Previous 1 2 3 4 Next >
Enfusion Announces Date of First Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Partnership With Leading Risk Management Provider Qontigo
From Enfusion, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
Via Benzinga
What 4 Analyst Ratings Have To Say About Enfusion
Via Benzinga
Analyst Ratings for Enfusion
Via Benzinga
Why Enfusion Stock Surged Today
The company is growing profitably -- unusual for a small software company. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023
Via Benzinga
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Enfusion Announces Fourth Quarter 2022 Results and Full Year 2022 Results
From Enfusion, Inc.
Via Business Wire
Enfusion's Earnings: A Preview
Via Benzinga
Looking Into Enfusion's Return On Capital Employed
Via Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... 
Via Benzinga
Enfusion Announces Date of Fourth Quarter and Full Year 2022 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director
From Enfusion, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
Via Benzinga
Enfusion Names Oleg Movchan as Chief Executive Officer
From Enfusion, Inc.
Via Business Wire
Enfusion Appoints Brad Herring as New Chief Financial Officer
From Enfusion, Inc.
Via Business Wire
Enfusion Welcomes New Addition to Board of Directors
From Enfusion, Inc.
Via Business Wire
Nasdaq Down 50 Points; Crude Oil Rises Over 1%
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 50 points on Tuesday. 
Via Benzinga
Peering Into Enfusion's Recent Short Interest
Enfusion's (NYSE:ENFN) short percent of float has fallen 6.89% since its last report. The company recently reported that it has 2.13 million shares sold short, which is 7.43% of all regular shares that... 
Via Benzinga
Hibbett, Enfusion And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Via Benzinga
US Stocks Turn Lower; Dow Falls Over 100 Points
U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday. 
Via Benzinga
Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session
Gainers Otonomy, Inc. (NASDAQ: OTIC) shares surged 74.2% to $0.1866. Otonomy recently posted a Q3 loss of $0.18 per share. 
Via Benzinga
Enfusion Announces Resignation of Chief Financial Officer
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Third Quarter 2022 Results
From Enfusion, Inc.
Via Business Wire
Earnings Preview: Enfusion
Enfusion (NYSE:ENFN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Enfusion will report... 
Via Benzinga
Enfusion Announces Third Quarter 2022 Earnings Release Date
From Enfusion, Inc.
Via Business Wire
Apex Group Selects Enfusion Platform to Enhance Daily Middle-Office Services Offering
From Enfusion, Inc.
Via Business Wire
Expert Ratings for Enfusion
Over the past 3 months, 4 analysts have published their opinion on Enfusion (NYSE:ENFN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.